Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
8 March 2017
E-001581-17
Question for written answer
to the Commission
Rule 130
João Ferreira (GUE/NGL)

 Subject:  Use of diclofenac for veterinary purposes in the EU (III)
 Answer(s) 
Following on from previous questions on the use of diclofenac for veterinary purposes in the EU (E-009337-14 and E-003922-15), and given the recent warnings from Portuguese environmental NGOs on the threats to highly endangered vultures and large carrion-eating eagles (a species protected by national and EU legislation) and to their ecosystems, I should like some further information from the Commission on the developments to date. In particular:
1. What is the state of play with the risk-reduction steps recommended by the European Medicines Agency (Committee for Medicinal Products for Veterinary Use) in the Member States and with related action plans?
2. What evaluation has been conducted to date to gauge the suitability of each Member State’s legislation on populations of carrion-eating birds in its territory?
3. What is the state of play on the possibility of banning diclofenac for veterinary use and replacing it with the safe alternatives available, such as meloxicam?
Original language of question: PT 
Last updated: 27 March 2017Legal notice